UBS Upgrades Rivian Despite Insider Selling Near Recent Highs
UBS upgraded Rivian on Monday, citing R2 demand and margin outlook, driving a 12.1% single-session rally after the stock fell 19% on Q3 earnings. The timing is awkward: every insider open-market sale
UBS Upgrades Rivian After 19% Post-Earnings Drop
NEW YORK, November 2 —
UBS upgraded Rivian Automotive, Inc. (RIVN) on Monday, calling the post-Q3 19% sell-off a buying opportunity and lifting shares 12.1% in a single session. The endorsement arrives against an awkward backdrop: every open-market insider sale in the preceding 90 days cleared between $14.50 and $16.29, all above the stock's $13.24 recovery price.
- Q3 EPS of -$0.63 beat the - consensus estimate by 13.7%; Rivian also raised its full-year delivery forecast.
- Insider open-market sales by the CAO and departing CFO cleared between $14.50 and $16.29 in the 90 days before Q3.
- UBS's upgrade cited R2 demand and margin outlook; consensus analyst price target stands at $18.16, implying 37% upside.
Four Consecutive Beats Built the Upgrade Case
Rivian makes the R1T electric pickup, the R1S three-row electric SUV, and the EDV commercial delivery van built in collaboration with Amazon.com, Inc. Four straight quarters of beating consensus EPS estimates, with positive surprises ranging from 13.7% to 54.5%, represent a track record unusual for a manufacturer still scaling production. Q3 software revenue and R2 deliveries both grew, per CNBC, while trailing twelve-month revenue reached $6.48 billion, up 38.3% year-over-year. UBS, citing R2 demand and a favorable margin outlook, called the 19% post-earnings decline a buying opportunity; shares rose 12.1% the day of the upgrade.
Every Open-Market Sale Cleared Above Recovery
Per Form 4 filings, Chief Administrative Officer Michael Callahan sold 30,000 shares in two transactions: 15,000 at $16.29 on September 11 and 15,000 at $15.00 on October 1. CFO Claire McDonough sold 13,144 shares at $14.50 and 8,023 at $16.00 on August 18 and 20, in the week before Rivian disclosed her departure via an 8-K filed August 27. One day after the Q3 earnings 8-K, McDonough disposed of 730,292 shares in a non-market transaction. All four open-market transactions cleared above the stock's current level; the lowest, at $1.26 above $13.24, was McDonough's August 18 sale.
| Ticker | Mkt cap | Fwd P/E | 52-wk |
|---|---|---|---|
| RIVN | $19.2B | n/a | -7.8% |
| LCID | $1.2B | n/a | -81.9% |
| NIO | $8.1B | 25.8x | -56.7% |
| COIN | $36.0B | 55.0x | -56.6% |
| RBLX | $30.5B | n/a | -60.1% |
| QS | $2.5B | n/a | -75.0% |
The R2 Ramp Is the Next Checkpoint
UBS's case hinges on whether R2 margin improves enough in coming quarters to justify a recovery above the prices at which insiders sold. The Q3 8-K, filed October 29, paired earnings results with an Item 5.02 officer departure or appointment notice, a combination that added to the stock's initial post-earnings drop to $11.37. The next delivery report and any updated R2 cost commentary will be the concrete checkpoint, with the $18.16 consensus target as the valuation benchmark to test against. For investors working through that spread, the DCF calculator offers a starting frame. Run the free Rivian Automotive, Inc. deep-dive →
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
Frequently Asked Questions
What did UBS say about Rivian?
UBS upgraded Rivian on Monday, calling the post-Q3 19% sell-off a buying opportunity. The upgrade cited R2 demand and a favorable margin outlook; shares rose 12.1% the day of the upgrade.
Did Rivian beat earnings in Q3?
Yes, Q3 EPS of -$0.63 beat the consensus estimate of -$0.728 by 13.7%. Rivian also raised its full-year delivery forecast.
How much upside do analysts see?
Consensus analyst price target stands at $18.16, implying 37% upside from the stock's post-upgrade recovery price of $13.24.
Why is insider selling noteworthy here?
Every open-market insider sale in the preceding 90 days cleared between $14.50 and $16.29, all above the current recovery price. Chief Administrative Officer Michael Callahan and departing CFO Claire McDonough sold at these higher prices.
What's the path forward for the stock?
The R2 ramp is the next checkpoint for Rivian's recovery. The next delivery report and any updated R2 cost commentary will determine whether the stock can reach the $18.16 consensus target.
UBS upgraded Rivian on Monday, calling the stock's post-Q3-earnings 19% decline a buying opportunity and pushing shares up 12.1% in a single session. The endorsement arrives even as every open-market insider sale in the preceding 90 days cleared at prices between $14.50 and $16.29 — all above the stock's $13.24 recovery level.